Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nikolaos Vlachogiannis"'
Autor:
Irene Lambrinoudaki, Elena Armeni, Dimitrios Delialis, Georgios Georgiopoulos, Simon Tual-Chalot, Nikolaos Vlachogiannis, Raphael Patras, Evmorfia Aivalioti, Areti Augoulea, Nikolaos Tsoltos, Anastasia Soureti, Konstantinos Stellos, Kimon Stamatelopoulos
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74dd7d546df896c706567fbaf07b6b77
https://doi.org/10.1530/endoabs.81.p274
https://doi.org/10.1530/endoabs.81.p274
Autor:
Angel Rodriguez, Jesus Reviriego, Vasilios Karamanos, Franciso J del Canizo, Nikolaos Vlachogiannis, Vangelis Drossinos, the ECLA Study Group
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 10, Iss 1, p 18 (2011)
Cardiovascular Diabetology, Vol 10, Iss 1, p 18 (2011)
Background Type 2 diabetes (T2D) is strongly associated with cardiovascular risk and requires medications that improve glycemic control and other cardiovascular risk factors. The authors aimed to assess the relative effectiveness of pioglitazone (Pio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba8110102928b5f6d8ba545863828efb
https://doi.org/10.1186/1475-2840-10-18
https://doi.org/10.1186/1475-2840-10-18